Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

Biotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In ...

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The pharma industry is expected to grow 4.7% annually, reaching $1.4 trillion by 2029. [Sign up for stock news with our Invested newsletter.] Not only are pharmaceutical stocks excellent defensive ...

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...

We recently published a list of 10 Best Stocks to Buy and Hold For 2025. In this article, we are going to take a look at ...

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...